Vyome Holdings (HIND) Current Leases (2019 - 2026)
Vyome Holdings (HIND) posted quarterly Current Leases of $22548.0 for Q1 2026, down 80.56% year-over-year from $116000.0 in Q1 2025, and down 27.86% quarter-over-quarter from $31258.0 in Q4 2025.
Vyome Holdings (HIND) Current Leases (2019 - 2026) Analysis & Trends
Vyome Holdings' Current Leases history runs 8 years deep, the most recent figure standing at $22548.0 for Q1 2026.
- In Q1 2026, Current Leases fell 80.56% year-over-year to $22548.0; the TTM figure through Mar 2026 stood at $22548.0 (down 80.56% YoY), while the FY2025 annual figure was $31258.0, up 11.54% from the prior year.
- Current Leases for Q1 2026 stood at $22548.0, down from $31258.0 in the prior quarter.
- The five-year high for Current Leases was $441000.0 in Q1 2022, with the low at $22548.0 in Q1 2026.
- The 5-year median for Current Leases is $111000.0 (2023), against an average of $134840.5.
- The sharpest annual moves came in 2024 and 2026: Current Leases jumped 30.23% in 2024, then slumped 80.56% in 2026.
- Vyome Holdings' Current Leases stood at $171000.0 in 2022, then slumped by 35.09% to $111000.0 in 2023, then sank by 74.75% to $28024.0 in 2024, then grew by 11.54% to $31258.0 in 2025, then retreated by 27.86% to $22548.0 in 2026.
- Business Quant data shows HIND's Current Leases at $22548.0 in Q1 2026, $31258.0 in Q4 2025, and $30458.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | - |
| 10 | Vyome Holdings | 16.28 Mn | 9.66 Mn | 11,658.00 | 17,310.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17,310.00 |
| Mar 31, 2026 | 22,548.00 |
| Dec 31, 2025 | 31,258.00 |
| Sep 30, 2025 | 30,458.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 28,024.00 |
| Sep 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 113,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 111,000.00 |
| Sep 30, 2023 | 110,000.00 |
| Jun 30, 2023 | 109,000.00 |
| Mar 31, 2023 | 86,000.00 |
| Dec 31, 2022 | 171,000.00 |
| Sep 30, 2022 | 255,000.00 |
| Jun 30, 2022 | 338,000.00 |
| Mar 31, 2022 | 441,000.00 |
| Dec 31, 2021 | 279,000.00 |
| Sep 30, 2021 | 473,000.00 |